Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Urica Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Urica Therapeutics

Urica Therapeutics

Seed

Urica Therapeutics, a Fortress Biotech subsidiary, develops pharmaceuticals for gout and kidney diseases.

HQ
Bay Harbor Islands, FL, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Urica Therapeutics, founded as a subsidiary of Fortress Biotech, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing pharmaceutical products aimed at treating gout and chronic kidney diseases. The company's core mission is to innovate and provide effective treatments for these conditions, improving patient outcomes and quality of life. Urica's primary product in development is Dotinurad, a novel therapeutic for gout, which is currently undergoing clinical trials.

Notable figures associated with Urica Therapeutics include key members of its management team, board of directors, and scientific advisory board, who bring extensive experience in biopharmaceutical development. The company has achieved significant milestones in advancing Dotinurad through various stages of clinical trials, reflecting its commitment to addressing unmet medical needs. Urica's impact lies in its potential to offer new, effective treatments for patients suffering from gout and chronic kidney diseases, contributing to the broader field of biopharmaceutical innovation.

Urica Therapeutics - Similar Companies

Arthrosi Therapeutics logo

Arthrosi Therapeutics

arthrosi.com

UroGen Pharma logo

UroGen Pharma

urogen.com

United Therapeutics logo

United Therapeutics

EnzymeRx logo

EnzymeRx

Outpost Medicine logo

Outpost Medicine

River 3 Renal logo

River 3 Renal

Renibus Therapeutics logo

Renibus Therapeutics

Unicycive Therapeutics logo

Unicycive Therapeutics

unicycive.com

Elgia Therapeutics logo

Elgia Therapeutics

Novita Therapeutics logo

Novita Therapeutics

NephroDI Therapeutics logo

NephroDI Therapeutics

nephrodi.com

Apricus Biosciences logo

Apricus Biosciences

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Azora Therapeutics logo

Azora Therapeutics

UTR Therapeutics logo

UTR Therapeutics

Urica Therapeutics - Quick Facts

Who are Urica Therapeutics' competitors?

Companies similar to Urica Therapeutics include Arthrosi Therapeutics, UroGen Pharma, United Therapeutics and EnzymeRx.

When was Urica Therapeutics founded?

Urica Therapeutics was founded in 2021.

Where is Urica Therapeutics' headquarters located?

Urica Therapeutics' headquarters is located in Bay Harbor Islands, FL, US.

When was Urica Therapeutics' last funding round?

Urica Therapeutics' most recent funding round was for $2.5M (USD) in January 2023.

How much has Urica Therapeutics raised to-date?

As of Jan 5, 2023, Urica Therapeutics has raised a total of $2.5M (USD).

How many employees does Urica Therapeutics have?

Urica Therapeutics has 5 employees as of Feb 5, 2024.

Urica Therapeutics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified